Novel Anticancer Strategies (Volume II)

Novel Anticancer Strategies (Volume II) reviews important findings and updates within the cancer therapy field of great interest to those in academic research studying the development and validation of novel anticancer approaches. The Editor invited preeminent specialists to contribute to original a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Erakunde egilea: Bousbaa, Hassan
Formatua: Livro
Hizkuntza:Inglês
Argitaratua: MDPI - Multidisciplinary Digital Publishing Institute 2023
Gaiak:
bic Book Industry Communication::M Medicine
bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine::MJC Diseases & disorders::MJCL Oncology
Breast cancer treatment
Photodynamic therapy
Inorganic nanoparticles
Active targeting
cathepsins
BAX
MOMP
ubiquitination
apoptosis
chemotherapy
cancer
nanoerythrosome
nanoerythrocyte
nanovesicles
biomimetic
cancer therapy
diagnostics
imaging agents
cell cycle
cyclin-dependent kinase
p16
p21
p27
breast cancer
prognosis
drug delivery
HL60
leukemia
prodrug
resistance
retinoic acid
vitamin K
drug repurposing
COVID-19
pandemic
vaccination
multi-drug resistance
enhanced permeation and retention effect
nanotherapeutics
cancer theranostic
clinical translation
cell-penetrating peptides
protein transduction domains
tumor imaging
targeted therapies
dog
comparative oncology
molecular targets
spheroids
tumoroids
hydrogel
collagen
agarose
mammary spheroids
tissue engineering
cisplatin
melanoma
melanin nanoparticles
cytotoxicity
laser medical applications
hyperthermia
antimitotics
mitotic slippage
spindle assembly checkpoint
clinical trials
TRAIL
cancer stem cells
TRAIL resistance
angiogenesis
on-demand drug delivery systems
electrospun nanofibers
poly (N-isopropylacrylamide)
gold nanorods
paclitaxel
β-Cyclodextrin
SPIONs
metallodrugs
RAPTA derivatives
phosphino-amine ligands
CTCs
NSCLCs
metastasis suppression
curcumin
flavonoids
TNBC
immunotherapy
immune checkpoint
nanocarrier
combinational immunotherapy
lung cancer
miRNA
oncomiRs
photodynamic therapy PDT
porphyrin
iron oxide nanoparticles
mesoporous silica nanoparticles
antibody functionalization
targeted drug delivery systems
molecular-targeted therapies
multifunctional enzymes
HCC
CHRNA5
metastasis
stemness property
sorafenib sensitivity
neoantigens
vaccine
Patched
chemotherapy resistance
metastases
persistent cells
adrenocortical carcinoma
BUB3
mitosis
senescence
anticancer target
boron neutron capture therapy
4-borono-l-phenylalanine
drug discovery
solubility
mebendazole
polymer
HPMA
controlled drug release
PLK1
BI2536
Navitoclax
slippage
PD-1
gemcitabine
new anti-cancer drugs
precision medicine
undruggable targets
non-coding RNAs
oligonucleotide therapeutics
n/a
Sarrera elektronikoa:https://directory.doabooks.org/handle/20.500.12854/98933
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak